News

Revenue from the chemical products segment was $12.1m, or 23% of total revenue, for the second quarter of 2011, an increase of 3%from $11.8m in the corresponding period

The preclinical study results demonstrated that ME-143 showed anti-tumor activity against tumor cell lines, including breast, colorectal and ovarian. Additionally, ME-143 has also shown an ability to enhance

The milestone was paid for achieving key scientific milestones following independent scientific review of the company’s ongoing R&D projects. The payment is part of the previously announced five-year,

The Complete EHRs are 2011/2012 compliant and have been certified by InfoGard Laboratories, an ONC-ATCB certification body. Axolotl EMR Lite aids physicians to connect with the HIE and

The new plant will engaged in the manufacturing of premium powdered milk products for Chinese infants and children. Abbott expects to recruit around 300 people in the new

Eisai Laboratorios (Eisai Mexico) initially will focus to establish strategies and an initial infrastructure to support its operations debut into the Mexican market. It is the company’s second

The application was submitted to FDA on the basis of results from a 24-week study assessing 84 patients with central precocious puberty. In the trial, the enrolled patients

The report, ‘Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021,’ says that the market will grow with a CAGR of 8.7% between 2010 and 2016, with finished dosage forms

The AAALAC accreditation insures clients that studies performed at SoBran’s facility will be conducted with the utmost regard for the humane treatment of animals. ISO 9001:2008 certification reflects